43.03
price up icon0.12%   0.05
after-market アフターアワーズ: 43.60 0.57 +1.32%
loading
前日終値:
$42.98
開ける:
$42.65
24時間の取引高:
2.32M
Relative Volume:
1.31
時価総額:
$6.85B
収益:
$705.14M
当期純損益:
$-453.90M
株価収益率:
-14.15
EPS:
-3.04
ネットキャッシュフロー:
$-551.29M
1週間 パフォーマンス:
+1.86%
1か月 パフォーマンス:
+7.74%
6か月 パフォーマンス:
+34.89%
1年 パフォーマンス:
-16.15%
1日の値動き範囲:
Value
$42.28
$43.40
1週間の範囲:
Value
$40.81
$45.66
52週間の値動き範囲:
Value
$23.95
$50.43

Ionis Pharmaceuticals Inc Stock (IONS) Company Profile

Name
名前
Ionis Pharmaceuticals Inc
Name
セクター
Healthcare (1164)
Name
電話
(760) 931-9200
Name
住所
2855 GAZELLE COURT, CARLSBAD, CA
Name
職員
927
Name
Twitter
@ionispharma
Name
次回の収益日
2024-11-06
Name
最新のSEC提出書
Name
IONS's Discussions on Twitter

IONS を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
IONS
Ionis Pharmaceuticals Inc
43.03 6.85B 705.14M -453.90M -551.29M -3.04
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
462.13 117.32B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
558.87 58.89B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
401.80 51.14B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
673.80 41.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
299.01 32.59B 3.81B -644.79M -669.77M -6.24

Ionis Pharmaceuticals Inc Stock (IONS) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-07-01 アップグレード Barclays Equal Weight → Overweight
2025-04-07 開始されました H.C. Wainwright Buy
2025-03-31 開始されました Redburn Atlantic Neutral
2024-08-02 ダウングレード BMO Capital Markets Outperform → Market Perform
2024-07-24 アップグレード Leerink Partners Market Perform → Outperform
2024-07-16 再開されました Jefferies Buy
2024-06-14 アップグレード Bernstein Underperform → Mkt Perform
2024-04-10 アップグレード Wolfe Research Peer Perform → Outperform
2024-01-02 アップグレード BofA Securities Neutral → Buy
2023-10-23 アップグレード BofA Securities Underperform → Neutral
2023-09-29 開始されました Raymond James Strong Buy
2023-07-31 アップグレード Citigroup Neutral → Buy
2023-06-07 再開されました Piper Sandler Overweight
2023-05-04 アップグレード Citigroup Sell → Neutral
2023-03-21 開始されました Bernstein Underperform
2022-12-21 ダウングレード Morgan Stanley Overweight → Equal-Weight
2022-09-09 再開されました Morgan Stanley Overweight
2022-07-18 再開されました Oppenheimer Outperform
2022-03-31 再開されました Piper Sandler Overweight
2022-03-01 開始されました Citigroup Sell
2022-03-01 開始されました Guggenheim Buy
2022-02-01 ダウングレード BofA Securities Buy → Underperform
2021-12-14 アップグレード William Blair Mkt Perform → Outperform
2021-05-07 アップグレード UBS Sell → Neutral
2021-03-01 アップグレード Barclays Underweight → Equal Weight
2020-12-16 開始されました UBS Sell
2020-12-15 アップグレード Cowen Market Perform → Outperform
2020-09-14 再開されました JP Morgan Neutral
2020-09-02 開始されました The Benchmark Company Hold
2020-06-01 再開されました Oppenheimer Outperform
2020-05-13 開始されました RBC Capital Mkts Outperform
2020-03-05 開始されました Citigroup Buy
2019-12-13 開始されました Oppenheimer Outperform
2019-11-13 開始されました BofA/Merrill Buy
2019-11-07 ダウングレード Morgan Stanley Equal-Weight → Underweight
2019-09-10 アップグレード Bernstein Mkt Perform → Outperform
2018-08-08 繰り返されました Stifel Hold
2018-08-07 繰り返されました Stifel Hold
2018-05-08 ダウングレード Evercore ISI Outperform → In-line
2017-10-06 再開されました Goldman Sell
2017-08-17 開始されました Evercore ISI Outperform
2017-08-09 繰り返されました Stifel Hold
2017-03-10 ダウングレード Goldman Neutral → Sell
2016-12-28 繰り返されました BMO Capital Markets Outperform
2016-12-27 繰り返されました Leerink Partners Mkt Perform
すべてを表示

Ionis Pharmaceuticals Inc (IONS) 最新ニュース

pulisher
12:57 PM

Analysts Just Published A Bright New Outlook For Ionis Pharmaceuticals, Inc.'s (NASDAQ:IONS) - simplywall.st

12:57 PM
pulisher
11:51 AM

How does Ionis Pharmaceuticals Inc. generate profit in a changing economyAI Powered Target Finder For Consistent Profits - jammulinksnews.com

11:51 AM
pulisher
11:48 AM

Diabetes Pipeline 2025: Therapies Under Investigation, - openPR.com

11:48 AM
pulisher
11:00 AM

How volatile is Ionis Pharmaceuticals Inc. stock compared to the marketPre Market Trend Scanner With High Returns - jammulinksnews.com

11:00 AM
pulisher
09:51 AM

Ionis Beats on Q2 Earnings & Sales, Stock Up 5% on Raised '25 Outlook - MSN

09:51 AM
pulisher
08:13 AM

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Q2 2025 Earnings Call Transcript - Insider Monkey

08:13 AM
pulisher
07:06 AM

Ionis Pharmaceuticals Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance

07:06 AM
pulisher
Jul 31, 2025

Ionis Pharmaceuticals Reports Strong Earnings and Growth - TipRanks

Jul 31, 2025
pulisher
Jul 31, 2025

Morgan Stanley Upgrades Ionis Pharmaceuticals (IONS) - MSN

Jul 31, 2025
pulisher
Jul 31, 2025

Ionis raises 2025 revenue guidance to $850M with Tryngolza momentum and Donidalorsen launch on track - MSN

Jul 31, 2025
pulisher
Jul 31, 2025

How does Ionis Pharmaceuticals Inc. compare to its industry peersAI Powered Tips With High Returns - jammulinksnews.com

Jul 31, 2025
pulisher
Jul 31, 2025

Ionis (IONS) Q2 Revenue Soars 101% - The Globe and Mail

Jul 31, 2025
pulisher
Jul 31, 2025

Raymond James Raises Ionis Pharmaceuticals (IONS) Price Target t - GuruFocus

Jul 31, 2025
pulisher
Jul 31, 2025

UK Approves Biogen’s Qalsody After England Revises Reimbursement Approach - insights.citeline.com

Jul 31, 2025
pulisher
Jul 31, 2025

Ionis Pharmaceuticals stock price target raised to $65 from $50 at H.C. Wainwright - Investing.com Canada

Jul 31, 2025
pulisher
Jul 31, 2025

Ionis reports second quarter 2025 financial results and highlights progress on key programs - BioSpace

Jul 31, 2025
pulisher
Jul 31, 2025

Ionis Pharmaceuticals Inc (IONS) Q2 2025 Earnings Call Highlights: Revenue Surge and Strategic ... - Yahoo Finance

Jul 31, 2025
pulisher
Jul 31, 2025

Ionis Pharmaceuticals Reports Strong Q2 2025 Results - TipRanks

Jul 31, 2025
pulisher
Jul 30, 2025

Morgan Stanley upgrades Ionis Pharmaceuticals stock rating on strong Tryngolza launch - Investing.com India

Jul 30, 2025
pulisher
Jul 30, 2025

Ionis Pharmaceuticals' 2025 Q2 Earnings: A Launch-Driven Growth Story with Multi-Billion-Dollar Potential - AInvest

Jul 30, 2025
pulisher
Jul 30, 2025

Ionis Pharmaceuticals, Inc. 2025 Q2ResultsEarnings Call Presentation (NASDAQ:IONS) - Seeking Alpha

Jul 30, 2025
pulisher
Jul 30, 2025

Earnings call transcript: Ionis Pharmaceuticals Q2 2025 Surpasses Revenue Expectations - Investing.com Australia

Jul 30, 2025
pulisher
Jul 30, 2025

Ionis (IONS) Q2 2025 Earnings Call Transcript - AOL.com

Jul 30, 2025
pulisher
Jul 30, 2025

Why Ionis Pharmaceuticals Shares Are Up After Q2 ReportIonis Pharmaceuticals (NASDAQ:IONS) - Benzinga

Jul 30, 2025
pulisher
Jul 30, 2025

Ionis Q2 2025 slides: TRYNGOLZA sales surge as pipeline advances By Investing.com - Investing.com Canada

Jul 30, 2025
pulisher
Jul 30, 2025

Ionis Pharmaceuticals Reports Strong Q2 2025 Financial Results - TradingView

Jul 30, 2025
pulisher
Jul 30, 2025

Ionis Pharmaceuticals' Q2 Outperformance and Strategic Pipeline Catalysts: A High-Conviction Buy Before Earnings Release? - AInvest

Jul 30, 2025
pulisher
Jul 30, 2025

Ionis Pharmaceuticals Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Jul 30, 2025
pulisher
Jul 30, 2025

Here's What Key Metrics Tell Us About Ionis Pharmaceuticals (IONS) Q2 Earnings - Yahoo Finance

Jul 30, 2025
pulisher
Jul 30, 2025

Ionis Pharmaceuticals: Q2 Earnings Snapshot - The Washington Post

Jul 30, 2025
pulisher
Jul 30, 2025

Ionis Pharmaceuticals Inc. May Be Forming Higher Low — Chartwatchers AlertStock Market Entry Timing Signals Revealed - metal.it

Jul 30, 2025
pulisher
Jul 30, 2025

Ionis Pharmaceuticals (IONS) Q2 Earnings and Revenues Beat Estimates - Yahoo Finance

Jul 30, 2025
pulisher
Jul 30, 2025

Is Ionis Pharmaceuticals (NASDAQ:IONS) Using Too Much Debt? - simplywall.st

Jul 30, 2025
pulisher
Jul 29, 2025

Analysts Are Bullish on These Healthcare Stocks: Ionis Pharmaceuticals (IONS), Janux Therapeutics Inc (JANX) - The Globe and Mail

Jul 29, 2025
pulisher
Jul 29, 2025

Ionis Pharmaceuticals (IONS) Received Positive Opinion from European Medicines Agency - Insider Monkey

Jul 29, 2025
pulisher
Jul 28, 2025

What is the dividend policy of Ionis Pharmaceuticals Inc. stockTop Growth Entry Points To Watch Now - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

What makes Ionis Pharmaceuticals Inc. stock price move sharplyDiscover stocks with superior performance - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Has Ionis Pharmaceuticals Inc. Stock Ever Crashed Historical Volatility Review Free Weekly Return Pick Forecast Reports - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

Is it the right time to buy Ionis Pharmaceuticals Inc. stockOutstanding trading profits - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Ionis Pharmaceuticals IONS 2025Q2 Earnings Preview Upside Potential on Revenue Growth - AInvest

Jul 28, 2025
pulisher
Jul 28, 2025

Why is Ionis Pharmaceuticals Inc. stock attracting strong analyst attentionGet timely alerts on market opportunities - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

What is the risk reward ratio of investing in Ionis Pharmaceuticals Inc. stockAchieve consistent double-digit returns - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 27, 2025

What are analysts’ price targets for Ionis Pharmaceuticals Inc. in the next 12 monthsStay ahead with daily expert stock picks - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Does Ionis Pharmaceuticals Inc. stock perform well during market downturnsSuperior return velocity - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What institutional investors are buying Ionis Pharmaceuticals Inc. stockInvest in stocks with strong fundamentals - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

When is Ionis Pharmaceuticals Inc. stock expected to show significant growthConsistently outstanding ROI - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 26, 2025

Ionis Pharmaceuticals Announces Positive Donidalorsen Results for Hereditary Angioedema Published in JACI In Practice - MSN

Jul 26, 2025
pulisher
Jul 25, 2025

Is Ionis Pharmaceuticals (NASDAQ:IONS) Using Debt Sensibly? - 富途牛牛

Jul 25, 2025
pulisher
Jul 25, 2025

Ionis Pharmaceuticals Gains CHMP Approval for Tryngolza: Analysts Project 36.63% Upside - AInvest

Jul 25, 2025
pulisher
Jul 25, 2025

Ionis Pharmaceuticals Inc. Stock Analysis and ForecastFree Stock Market Real-Time Monitoring - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

KalVista, Biogen, Ionis get EU positive opinions for key drugs (KALV:NASDAQ) - Seeking Alpha

Jul 25, 2025

Ionis Pharmaceuticals Inc (IONS) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Ionis Pharmaceuticals Inc (IONS) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
LOSCALZO JOSEPH
Director
Jul 15 '25
Option Exercise
0.00
4,079
0
36,330
YANG MICHAEL J.
Director
Jul 15 '25
Option Exercise
0.00
4,079
0
6,010
WENDER JOSEPH H
Director
Jul 15 '25
Option Exercise
0.00
4,079
0
136,835
PARSHALL B LYNNE
Director
Jul 15 '25
Option Exercise
0.00
4,079
0
91,344
HERMAN JOAN E
Director
Jul 15 '25
Option Exercise
0.00
4,079
0
46,086
Hayden Michael R
Director
Jul 15 '25
Option Exercise
0.00
4,079
0
54,298
Diaz Allene M.
Director
Jul 15 '25
Option Exercise
0.00
4,079
0
19,795
BERTHELSEN SPENCER R
Director
Jul 15 '25
Option Exercise
0.00
4,079
0
156,013
Monia Brett P
Chief Executive Officer
Jul 11 '25
Sale
41.74
1,160
48,416
179,820
Hayden Michael R
Director
May 01 '25
Buy
31.86
15,000
477,900
50,219
$75.59
price up icon 0.93%
$37.11
price up icon 0.84%
$108.69
price up icon 1.31%
$27.07
price up icon 2.65%
$107.34
price down icon 0.15%
biotechnology ONC
$299.01
price down icon 0.70%
大文字化:     |  ボリューム (24 時間):